Growth rate of acoustic neuroma expressed by ki-67 nuclear antigen versus symptom duration

Annals of Otology, Rhinology & Laryngology

Volumn 102, Issue 10, 1993, Pages 805-809

  Charabi, Samih ^a   Tos, Mirko ^a   Thomsen, Jens ^a   Engel, Peter ^a   Jacobsen, Grete Krag ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

acoustic neuroma; monoclonal antibody; symptom duration; tumor proliferative fraction

Indexed keywords

CELL NUCLEUS ANTIGEN;

ACOUSTIC NEURINOMA; ADULT; AGED; ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; FEMALE; GROWTH RATE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL;

ADULT; AGED; ANTIGENS, CD30; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGE; NEUROMA, ACOUSTIC;

EID: 0027485192     PISSN: 00034894     EISSN: 19433572     Source Type: Journal    
DOI: 10.1177/000348949310201013     Document Type: Article

References (16)

1. Olivecrona H. Acoustic tumors. J Neurosurg 1967; 26: 6–13.
2. Quinn CM, Wright NA. The clinical assessment of proliferation and growth in human tumors. Evaluation of methods and applications as prognostic valuables. J Pathol 1990; 160: 93–102.
3. Donhuijsen K, Schmidt U, Hiche H van Beuningen D Budach V. Changes in mitotic rate and cell cycle fractions caused by delayed fixation. Hum Pathol 1990; 21: 709–714.
4. Ellis PSI, Whitehead R. Mitosis counting — A need for reappraisal. Hum Pathol 1981; 12: 3–4.
5. Meyer JS, Coplin MD. Thymidine labeling index, flow cytometric S-phase measurement, and DNA index in human tumors. Comparison and correlation. Am J Clin Pathol 1988; 89: 586–595.
6. Johnson HA, Bond VP. A method of labeling tissues with triated thy midine in vitro and its use in comparing rates of cellular proliferation in duct epithelium. Fibroadenoma and carcinoma of human breast. Cancer 1961; 14: 639–643.
7. Rasmussen N, Tribukait B, Thomsen J Holm LE Tos M. Implications of DNA characterization of human acoustic neuromas. Acta Otolaryngol [Suppl] (Stockh) 1984 (suppl 406): 278–281.
8. Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with human nuclear antigen associated with cell proliferation. Int J Cancer 1983: 31: 13–20.
9. Garcia RL, Coltrera MD, Gown AM. Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analysis. Am J Pathol 1989; 134: 733–739.
10. Tsutsumi Y, Hori S, Onoda N. DNA polymerase alpha: An immunohistochemical marker for proliferating cells in normal and neoplastic human tissues. Am J Clin Pathol 1990; 93: 643–650.
11. Clevenger CV, Epstein AL, Bauer KD. Modulation of the nuclear antigen p105 as a function of cell-cycle progression. J Cell Physiol 1987; 130: 336–343.
12. Gerdes J, Lemke H, Baisch H Wacker HH Schwab U Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984; 133: 1710–1715.
13. Lesser JHT, Janzer CR, Kleinhues P, Fisch U. Clinical growth rate of acoustic schwannomas, correlation with the growth fraction as defined by the monoclonal antibody Ki-67. Skull Base Surg 1991; 1: 11–15.
14. Vanderberg RS. Current diagnostic concepts of astrocytic tumors. J Neuropathol Exp Neurol 1992; 51: 644–657.
15. Wennerberg J, Merche U. Growth potential of acoustic neuromas. Am J Otol 1989; 10: 293–296.
16. Olivecrona H. Analysis of results of complete and partial removal of acoustic neuromas. J Neurol Neurosurg Psychiatry 1950; 13: 271–272.